Cargando…
A phase Ib/II study of fruquintinib in combination with paclitaxel as the second‐line therapy for advanced gastric cancer
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9859731/ https://www.ncbi.nlm.nih.gov/pubmed/36331272 http://dx.doi.org/10.1002/cac2.12379 |
| _version_ | 1784874425487720448 |
|---|---|
| author | Zhang, Yang Wang, Zi‐Xian Shen, Lin Li, Jin Huang, Jing Su, Wei‐Guo Zhang, Dong‐Sheng Xu, Rui‐Hua |
| author_facet | Zhang, Yang Wang, Zi‐Xian Shen, Lin Li, Jin Huang, Jing Su, Wei‐Guo Zhang, Dong‐Sheng Xu, Rui‐Hua |
| author_sort | Zhang, Yang |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9859731 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98597312023-01-24 A phase Ib/II study of fruquintinib in combination with paclitaxel as the second‐line therapy for advanced gastric cancer Zhang, Yang Wang, Zi‐Xian Shen, Lin Li, Jin Huang, Jing Su, Wei‐Guo Zhang, Dong‐Sheng Xu, Rui‐Hua Cancer Commun (Lond) Letters to the Editor John Wiley and Sons Inc. 2022-11-04 /pmc/articles/PMC9859731/ /pubmed/36331272 http://dx.doi.org/10.1002/cac2.12379 Text en © 2022 The Authors. Cancer Communications published by John Wiley & Sons Australia, Ltd. on behalf of Sun Yat‐sen University Cancer Center. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Letters to the Editor Zhang, Yang Wang, Zi‐Xian Shen, Lin Li, Jin Huang, Jing Su, Wei‐Guo Zhang, Dong‐Sheng Xu, Rui‐Hua A phase Ib/II study of fruquintinib in combination with paclitaxel as the second‐line therapy for advanced gastric cancer |
| title | A phase Ib/II study of fruquintinib in combination with paclitaxel as the second‐line therapy for advanced gastric cancer |
| title_full | A phase Ib/II study of fruquintinib in combination with paclitaxel as the second‐line therapy for advanced gastric cancer |
| title_fullStr | A phase Ib/II study of fruquintinib in combination with paclitaxel as the second‐line therapy for advanced gastric cancer |
| title_full_unstemmed | A phase Ib/II study of fruquintinib in combination with paclitaxel as the second‐line therapy for advanced gastric cancer |
| title_short | A phase Ib/II study of fruquintinib in combination with paclitaxel as the second‐line therapy for advanced gastric cancer |
| title_sort | phase ib/ii study of fruquintinib in combination with paclitaxel as the second‐line therapy for advanced gastric cancer |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9859731/ https://www.ncbi.nlm.nih.gov/pubmed/36331272 http://dx.doi.org/10.1002/cac2.12379 |
| work_keys_str_mv | AT zhangyang aphaseibiistudyoffruquintinibincombinationwithpaclitaxelasthesecondlinetherapyforadvancedgastriccancer AT wangzixian aphaseibiistudyoffruquintinibincombinationwithpaclitaxelasthesecondlinetherapyforadvancedgastriccancer AT shenlin aphaseibiistudyoffruquintinibincombinationwithpaclitaxelasthesecondlinetherapyforadvancedgastriccancer AT lijin aphaseibiistudyoffruquintinibincombinationwithpaclitaxelasthesecondlinetherapyforadvancedgastriccancer AT huangjing aphaseibiistudyoffruquintinibincombinationwithpaclitaxelasthesecondlinetherapyforadvancedgastriccancer AT suweiguo aphaseibiistudyoffruquintinibincombinationwithpaclitaxelasthesecondlinetherapyforadvancedgastriccancer AT zhangdongsheng aphaseibiistudyoffruquintinibincombinationwithpaclitaxelasthesecondlinetherapyforadvancedgastriccancer AT xuruihua aphaseibiistudyoffruquintinibincombinationwithpaclitaxelasthesecondlinetherapyforadvancedgastriccancer AT zhangyang phaseibiistudyoffruquintinibincombinationwithpaclitaxelasthesecondlinetherapyforadvancedgastriccancer AT wangzixian phaseibiistudyoffruquintinibincombinationwithpaclitaxelasthesecondlinetherapyforadvancedgastriccancer AT shenlin phaseibiistudyoffruquintinibincombinationwithpaclitaxelasthesecondlinetherapyforadvancedgastriccancer AT lijin phaseibiistudyoffruquintinibincombinationwithpaclitaxelasthesecondlinetherapyforadvancedgastriccancer AT huangjing phaseibiistudyoffruquintinibincombinationwithpaclitaxelasthesecondlinetherapyforadvancedgastriccancer AT suweiguo phaseibiistudyoffruquintinibincombinationwithpaclitaxelasthesecondlinetherapyforadvancedgastriccancer AT zhangdongsheng phaseibiistudyoffruquintinibincombinationwithpaclitaxelasthesecondlinetherapyforadvancedgastriccancer AT xuruihua phaseibiistudyoffruquintinibincombinationwithpaclitaxelasthesecondlinetherapyforadvancedgastriccancer |